Home
Home

Synthes

Former Synthes Execs Excluded From Federal Healthcare Programs

Former Synthes Execs Excluded From Federal Healthcare Programs
Pharmalot
Submitted by moderatorj on Tue, 08/21/2012 - 21:25

J&J's Synthes recalls bone putty over fire risk

J&J's Synthes recalls bone putty over fire risk
FierceMedicalDevice

J&J unit recalls bone putty

J&J unit recalls bone putty
Reuters

Synthes Investor Suits Over J&J Takeover Dismissed

Synthes Investor Suits Over J&J Takeover Dismissed
Bloomberg

Johnson & Johnson: A Lucrative Buy On Synthes Acqusition

Johnson & Johnson: A Lucrative Buy On Synthes Acqusition
Seeking Alpha

Johnson & Johnson Upgraded On Synthes Approval

Johnson & Johnson Upgraded On Synthes Approval
Motley Fool
Submitted by moderatorj on Fri, 06/15/2012 - 13:28

J&J: $19.7B Synthes buyout should boost earnings

J&J: $19.7B Synthes buyout should boost earnings
Mass Device

J&J Rises: Synthes Deal Makes it an ‘Offensive’ and ‘Defensive’ Juggernaut

J&J Rises: Synthes Deal Makes it an ‘Offensive’ and ‘Defensive’ Juggernaut
Barron's

Johnson & Johnson wins US approval to buy Synthes

Johnson & Johnson wins US approval to buy Synthes
Reuters

Johnson & Johnson: Synthes Approval Will Push Stock Higher

Johnson & Johnson: Synthes Approval Will Push Stock Higher
Seeking Alpha